Efficacy and Safety of Low-dose Decitabine in Refractory Aplastic Anemia
Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
This is a phase 2, single-center, single-arm, open-label trial. Simon's two-stage design is
performed to evaluate the efficacy of low-dose Decitabine in refractory aplastic anemia.